On Buprenorphine Implants: Should It Be Widely Used For Medically Assisted Treatment?

  • Patrick Bailey Professional writer mainly in the fields of mental health, addiction, and living in recovery

Abstract

Buprenorphine implants are recognized as one of the routes to administer Medically Assisted Treatment (MAT). However, the use of these implants is far less compared to oral medications in battling substance abuse. This article explores the likely reasons why buprenorphine implants are not as commonly recommended, and whether it is a feasible option to consider it a mainstream type of treatment.

Downloads

Download data is not yet available.

Author Biography

Patrick Bailey, Professional writer mainly in the fields of mental health, addiction, and living in recovery

Professional writer mainly in the fields of mental health, addiction, and living in recovery

References

1. McKeganey N, Russell C, Cockayne L. Medically assisted recovery from opiate dependence within the context of the UK drug strategy: Methadone and Suboxone (buprenorphine-naloxone) patients compared. Journal of substance abuse treatment. 2013 Jan 1;44(1):97-102. Retrieved from https://www.sciencedirect.com/science/article/pii/S0740547212000803
2. US Food and Drug Administration. FDA approves the first buprenorphine implant for the treatment of opioid dependence. News Release. Silver Spring, MD: FDA. 2016 May 26. Retrieved from https://www.fda.gov/news-events/press-announcements/fda-approves-first-buprenorphine-implant-treatment-opioid-dependence
3. Food and Drug Administration. Subutex and Suboxone approved to treat opiate dependence. FDA Talk Paper T02-38. Retrieved February. 2002 Oct 8;19:2003. Retrieved from https://www.naabt.org/faq_answers.cfm?ID=2
4. Stewart SA, Domínguez-Robles J, Donnelly RF, Larrañeta E. Implantable polymeric drug delivery devices: classification, manufacture, materials, and clinical applications. Polymers. 2018 Dec;10(12):1379. Retrieved from https://www.mdpi.com/2073-4360/10/12/1379
5. White J, Bell J, Saunders JB, Williamson P, Makowska M, Farquharson A, Beebe KL. Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence. Drug and alcohol dependence. 2009 Jul 1;103(1-2):37-43. Retrieved from Open-label dose-finding trial of buprenorphine implants (Probuphine)® for treatment of heroin dependence
6. Bell JR, Butler B, Lawrance A, Batey R, Salmelainen P. Comparing overdose mortality associated with methadone and buprenorphine treatment. Drug and alcohol dependence. 2009 Sep 1;104(1-2):73-7. Retrieved from https://www.sciencedirect.com/science/article/abs/pii/S037687160900115X
Statistics
103 Views | 113 Downloads
How to Cite
1.
Bailey P. On Buprenorphine Implants: Should It Be Widely Used For Medically Assisted Treatment?. JDDT [Internet]. 15Aug.2020 [cited 23Apr.2021];10(4-s):214-6. Available from: http://jddtonline.info/index.php/jddt/article/view/4257